Skip to content Skip to footer
Subscribe Now
VIEWPOINTS_Olivier Harari_2023
VIEWPOINTS

Olivier Harari, VP, Early Clinical Development at Regeneron Shares his Views on Pozelimab’s BLA Acceptance for the US FDA Priority Review

Shots: Olivier highlighted the P-II/III data based on which Regeneron’s BLA for Pozelimab was accepted by the US FDA under priority review to treat adults and children with CHAPLE disease CHAPLE disease is driven by an overactivation of the complement system due to CD55 deficiency. Pozelimab blocks the activity of complement factor C5 and prevents…
July 17, 2023

Read more

Pre-Conference Interviews ISPE Singapore Conference & Exhibition 2023
EVENTS

Pre-Conference Interviews: ISPE Singapore Conference & Exhibition 2023

The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most renowned pharmaceutical manufacturing shows in Singapore for pharmaceutical and biomanufacturing professionals. The annual event highlights the best practices and services from manufacturing facility design to finished products. Click here to register now! We are thrilled to announce that we are taking the…
July 1, 2023

Read more

VIEWPOINTS_Sheri Lewis1_Dr. Ger Brophy2_2023
VIEWPOINTS

Sheri Lewis and Dr. Ger Brophy of Avantor Share Insights on the Opening of a New Distribution Centre

Shots: Sheri talked about the opening of the new distribution center in Dublin, Ireland. The opening of the center highlighted Avantor’s continued investment to expand its global footprint strengthening its ability to provide essential products and services to the markets Dr. Ger Brophy spoke about the key benefits of the center to global biopharma customers.…
June 12, 2023

Read more

VIEWPOINTS_Eric Halioua_2023
VIEWPOINTS

Eric Halioua, President & CEO at PDC*line Pharma Shares Insights on the Results from P-I/II Trial with PDC*lung01

Shots: Eric shared the results from the first immunological results of its PDC-LUNG-101 P-I/II trial with PDC*lung01 which is the company’s cancer vaccine candidate for Non-Small Cell Lung Cancer The results were presented at ESMO-IO 2022 elaborating on the safety, tolerability, immunogenicity, and preliminary clinical activity of the drug candidate The interview shows PDC*line’s vision…
June 1, 2023

Read more

VIEWPOINTS_Monica Mann_2023
VIEWPOINTS

Monica Mann, VP, of Medical Affairs for Global MS and Pipeline at Biogen Shares Insights on New Data on MS Therapies and Digital Health Research

Shots: Monica spoke about the new data from its multiple sclerosis therapies portfolio presented at the 38th ECTRIMS meeting The highlights from the presentation were the safety and efficacy results of Vumerity, patient-reported outcomes from the treatment with Tysabri, and posters highlighting advances in digital health initiatives The interview shows how Biogen develops, and delivers…
May 31, 2023

Read more

Viewpoints_Dr. Bina Naik and Dr. Ashish Indani
VIEWPOINTS

PharmaShots Interview: Impact of new regulations and trends in the medical device industry in India – interviews of Dr. Bina Naik and Dr. Ashish Indani during DIA Medical Device Conference 20

The Medical Devices Conference was hosted by DIA India on 21st and 22nd February in collaboration with the Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI Europa, is one of the largest gatherings of medical devices professionals in the region. The conference was focused on giving better insights into the challenges…
June 22, 2021

Read more